Download PDF
Dtsch Med Wochenschr 2013; 138(23): 1229-1232
DOI: 10.1055/s-0033-1343183
Nephrologie | Commentary
Nephrologie
© Georg Thieme Verlag KG Stuttgart · New York

Akutes Nierenversagen

Update 2013Acute kidney injuryUpdate 2013
A. Bienholz
1   Klinik für Nephrologie, Universität Duisburg-Essen, Universitätsklinikum Essen
,
T. Feldkamp
2   Klinik für Innere Medizin IV, Nieren- und Hochdruckkrankheiten, Universitätsklinikum Schleswig-Holstein, Christian Albrechts Universität zu Kiel
,
A. Kribben
1   Klinik für Nephrologie, Universität Duisburg-Essen, Universitätsklinikum Essen
› Author Affiliations
Further Information

Publication History

Publication Date:
29 May 2013 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

akutes Nierenversagen - Biomarker - KDIGO-Leitlinien

Keywords

acute kidney injury - biomarker - KDIGO guidelines
 

  • Literatur

  • 1 Ad-hoc working group of ERBP. . Fliser D, Laville M, Covic A et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1. Nephrol Dial Transplant 2012; 27: 4263-4272
    CrossrefPubMedGoogle Scholar
  • 2 Bienholz A, Kribben A, Feldkamp T. Akutes Nierenversagen – neue Erkenntnisse aus Diagnostik und Therapie. Dtsch Med Wochenschr 2012; 137: 652-655
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Bucaloiu I, Kirchner HL, Norfolk ER et al. Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury. Kidney Int 2012; 81: 477-485
    CrossrefPubMedGoogle Scholar
  • 4 Ejaz A, Dass B, Lingegowda V et al. Effect of uric acid lowering therapy on the prevention of acute kidney injury in cardiovascular surgery. Int Urol Nephrol 2013; 45: 449-458
    CrossrefPubMedGoogle Scholar
  • 5 Ho K, Power B. Benefits and risks of frusemide in acute kidney injury. Anaesthesia 2010; 65: 283-293
    CrossrefPubMedGoogle Scholar
  • 6 Ho K, Sheridan D. Meta-analysis of frusemide to prevent or treat acute renal failure. Brit Med J 2006; 333: 420 Epub 2006 Jul 21.
    CrossrefPubMedGoogle Scholar
  • 7 Kashani K, Al-Khafaji A, Ardiles T et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013; 17: R25 Feb 6 [Epub ahead of print]
    CrossrefPubMedGoogle Scholar
  • 8 Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2012; 2: 1-138
    CrossrefPubMedGoogle Scholar
  • 9 Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013; 3: 1-150
    CrossrefPubMedGoogle Scholar
  • 10 Lapsia V, Johnson RJ, Dass B et al. Elevated uric acid increases the risk for acute kidney injury. Am J Med 2012; 125: 302.e9-17
    PubMedGoogle Scholar
  • 11 Siew E, Matheny ME, Ikizler TA et al. Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury. Kidney Int 2010; 77: 536-542
    CrossrefPubMedGoogle Scholar
  • 12 Siew E, Peterson JF, Eden SK et al. Estimation baseline kidney function in hospitalized patients with impaired kidney function. Clin J Am Soc Nephrol 2012; 7: 712-719
    CrossrefPubMedGoogle Scholar
  • 13 Singbartl K, Kellum J. AKI in the ICU: definition, epidemiology, risk stratification, and outcomes. Kidney Int 2012; 81: 819-825
    CrossrefPubMedGoogle Scholar
  • 14 Zander R, Boldt J, Engelmann L et al. Studienprotokoll der VISEP-Studie. Anaesthesist 2007; 56: 71-77
    CrossrefPubMedGoogle Scholar